Decreased Plasma IL-35 Levels Are Related to the Left Ventricular Ejection Fraction in Coronary Artery Diseases

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Lin, Yingzhong ^a   Huang, Ying ^a   Lu, Zhengde ^a   Luo, Cheng ^a   shi, Ying ^a   Zeng, Qiutang ^b   Cao, Yifeng ^b   Liu, Lin ^a   Wang, Xiaoyan ^a   Ji, Qingwei ^a  

^a PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 27; INTERLEUKIN 35; LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ASPIRIN; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; STROKE VOLUME; TICLOPIDINE;

ANGINA;

EID: 84871391940     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052490     Document Type: Article

References (45)

1. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
2. Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, et al. (1999) Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145: 33-43.
3. Tedgui A, Mallat Z, (2006) Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways. Physiol Rev 86: 515-581.
4. Alam SE, Nasser SS, Fernainy KE, Habib AA, Badr KF, (2004) Cytokine imbalance in acute coronary syndrome. Curr Opin Pharmacol 4: 166-170.
5. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC, (2001) Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104: 746-749.
6. Mazzone A, De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, et al. (1999) Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145: 369-374.
7. Anguera I, Miranda-Guardiola F, Bosch X, Filella X, Sitges M, et al. (2002) Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J 144: 811-817.
8. Kilic T, Ural D, Ural E, Yumuk Z, Agacdiken A, et al. (2006) Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart 92: 1041-1046.
9. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, et al. (2003) Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107: 2109-2114.
10. Lebastchi AH, Qin L, Khan SF, Zhou J, Geirsson A, et al. (2011) Activation of human vascular cells decreases their expression of transforming growth factor-beta. Atherosclerosis 219: 417-424.
11. Ji QW, Guo M, Zheng JS, Mao XB, Peng YD, et al. (2009) Downregulation of T helper cell type 3 in patients with acute coronary syndrome. Arch Med Res 40: 285-293.
12. Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, et al. (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37: 3021-3029.
13. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, et al. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
14. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, et al. (1996) A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 70: 1143-1145.
15. Devergne O, Birkenbach M, Kieff E, (1997) Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A 94: 12041-12046.
16. Collison LW, Pillai MR, Chaturvedi V, Vignali DA, (2009) Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 182: 6121-6128.
17. Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, et al. (2011) Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 187: 462-471.
18. Wirtz S, Billmeier U, Mchedlidze T, Blumberg RS, Neurath MF, (2011) Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141: 1875-1886.
19. Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, et al. (2012) IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 129: 207-215.
20. Bardel E, Larousserie F, Charlot-Rabiega P, Coulomb-L'Herminé A, Devergne O, (2008) Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J Immunol 181: 6898-6905.
21. Allan SE, Song-Zhao GX, Abraham T, McMurchy AN, Levings MK, (2008) Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 38: 3282-3289.
22. Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA, (2011) Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 186: 6661-6666.
23. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, et al. (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11: 1093-1101.
24. Kochetkova I, Golden S, Holderness K, Callis G, Pascual DW, (2010) IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 184: 7144-7153.
25. Bettini M, Castellaw AH, Lennon GP, Burton AR, Vignali DA (2012) Prevention of Autoimmune Diabetes by Ectopic Pancreatic β-Cell Expression of Interleukin-35. Diabetes. [Epub ahead of print].
26. Kempe S, Heinz P, Kokai E, Devergne O, Marx N, et al. (2009) Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques. Am J Pathol 175: 440-447.
27. Redondo S, Ruiz E, Gordillo-Moscoso A, Navarro-Dorado J, Ramajo M, et al. (2010) Role of TGF-β1 and MAP Kinases in the Antiproliferative Effect of Aspirin in Human Vascular Smooth Muscle Cells. PLoS ONE 5: e9800.
28. Block RC, Dier U, Calderonartero P, Shearer GC, Kakinami L, et al. (2012) The effects of EPA+ DHA and aspirin on inflammatory cytokines and angiogenesis factors. World J Cardiovasc Dis 2: 14-19.
29. Hovens MM, Snoep JD, Groeneveld Y, Frölich M, Tamsma JT, et al. (2008) Effects of aspirin on serum C-reactive protein and interkin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled cross over trial. Diabetes Obes Metab 10: 668-674.
30. Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, et al. (1996) Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97: 2130-8.
31. Lee TS, Yen HC, Pan CC, Chau LY, (1999) The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19: 734-742.
32. Cao Y, Doodes PD, Glant TT, Finnegan A, (2008) IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 180: 922-30.
33. Tassi E, Braga M, Longhi R, Gavazzi F, Parmiani G, et al. (2009) Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients. PLoS One 4: e7234.
34. Jafarzadeh A, Nemati M, Rezayati MT, (2011) Serum levels of interleukin (IL)-27 in patients with ischemic heart disease. Cytokine 56: 153-6.
35. Tziakas DN, Chalikias GK, Hatzinikolaou HI, Parissis JT, Papadopoulos ED, et al. (2003) Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. Int J Cardiol 92: 169-175.
36. Bogavac-Stanojevic N, Djurovic S, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Kalimanovska-Ostric D, (2003) Circulating transforming growth factor-beta1, lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease. Clin Chem Lab Med 41: 893-898.
37. Niedobitek G, Päzolt D, Teichmann M, Devergne O, (2002) Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol 198: 310-316.
38. Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, et al. (2008) Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol 38: 1204-1214.
39. Liu JQ, Liu Z, Zhang X, Shi Y, Talebian F, et al. (2012) Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol 188: 3099-3106.
40. Seyerl M, Kirchberger S, Majdic O, Seipelt J, Jindra C, et al. (2010) Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol 40: 321-329.
41. Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, et al. (2012) The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 13: 290-299.
42. Liu F, Tong F, He Y, Liu H, (2011) Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin Immunol 139: 1-5.
43. de Boer OJ, Teeling P, Idu MM, Becker AE, van der Wal AC, (2006) Epstein Barr virus specific T-cells generated from unstable human atherosclerotic lesions: implications for plaque inflammation. Atherosclerosis 184: 322-329.
44. Li X, Mai J, Virtue A, Yin Y, Gong R, et al. (2012) IL-35 is a novel responsive anti-inflammatory cytokine-a new system of categorizing anti-inflammatory cytokines. PLoS One 7: e33628.
45. Mor A, Luboshits G, Planer D, Keren G, George J, (2006) Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 27: 2530-2537.